A Phase 1 Dose Escalation Study to Examine the Safety of the P2-VP8 Rotavirus Vaccine
NCT01764256
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Rotavirus Infection
Interventions
BIOLOGICAL:
P2-VP8 subunit rotavirus vaccine
OTHER:
placebo
Sponsor
PATH